Arthur Frederick Ryan's most recent trade in Regeneron Pharmaceuticals, Inc. was a trade of 200 Common Stock done at an average price of $650.2 . Disclosure was reported to the exchange on July 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 650.15 per share. | 02 Jul 2026 | 200 | 17,303 (0%) | 0% | 650.2 | 130,030 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 703.46 per share. | 01 May 2026 | 24 | 17,559 (0%) | 0% | 703.5 | 16,883 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 704.27 per share. | 01 May 2026 | 15 | 17,544 (0%) | 0% | 704.3 | 10,564 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 702.47 per share. | 01 May 2026 | 15 | 17,583 (0%) | 0% | 702.5 | 10,537 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 705.57 per share. | 01 May 2026 | 14 | 17,530 (0%) | 0% | 705.6 | 9,878 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 706.71 per share. | 01 May 2026 | 7 | 17,523 (0%) | 0% | 706.7 | 4,947 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 709.50 per share. | 01 May 2026 | 6 | 17,513 (0%) | 0% | 709.5 | 4,257 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 711.40 per share. | 01 May 2026 | 5 | 17,506 (0%) | 0% | 711.4 | 3,557 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 701.80 per share. | 01 May 2026 | 5 | 17,598 (0%) | 0% | 701.8 | 3,509 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 707.50 per share. | 01 May 2026 | 4 | 17,519 (0%) | 0% | 707.5 | 2,830 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 711.00 per share. | 01 May 2026 | 2 | 17,511 (0%) | 0% | 711 | 1,422 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 714.00 per share. | 01 May 2026 | 2 | 17,503 (0%) | 0% | 714 | 1,428 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 712.00 per share. | 01 May 2026 | 1 | 17,505 (0%) | 0% | 712 | 712 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 779.70 per share. | 01 Apr 2026 | 40 | 17,603 (0%) | 0% | 779.7 | 31,188 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 775.57 per share. | 01 Apr 2026 | 14 | 17,669 (0%) | 0% | 775.6 | 10,858 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 776.62 per share. | 01 Apr 2026 | 13 | 17,656 (0%) | 0% | 776.6 | 10,096 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 777.44 per share. | 01 Apr 2026 | 9 | 17,647 (0%) | 0% | 777.4 | 6,997 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 774.62 per share. | 01 Apr 2026 | 8 | 17,683 (0%) | 0% | 774.6 | 6,197 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 773.62 per share. | 01 Apr 2026 | 8 | 17,691 (0%) | 0% | 773.6 | 6,189 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 778.25 per share. | 01 Apr 2026 | 4 | 17,643 (0%) | 0% | 778.3 | 3,113 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 772.67 per share. | 01 Apr 2026 | 3 | 17,699 (0%) | 0% | 772.7 | 2,318 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 771.00 per share. | 01 Apr 2026 | 1 | 17,702 (0%) | 0% | 771 | 771 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 789.30 per share. | 02 Mar 2026 | 20 | 17,703 (0%) | 0% | 789.3 | 15,786 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 788.95 per share. | 02 Mar 2026 | 20 | 17,723 (0%) | 0% | 789.0 | 15,779 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 785.45 per share. | 02 Mar 2026 | 11 | 17,752 (0%) | 0% | 785.5 | 8,640 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 783.60 per share. | 02 Mar 2026 | 10 | 17,772 (0%) | 0% | 783.6 | 7,836 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 784.44 per share. | 02 Mar 2026 | 9 | 17,763 (0%) | 0% | 784.4 | 7,060 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 777.43 per share. | 02 Mar 2026 | 7 | 17,796 (0%) | 0% | 777.4 | 5,442 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 786.57 per share. | 02 Mar 2026 | 7 | 17,745 (0%) | 0% | 786.6 | 5,506 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 779.60 per share. | 02 Mar 2026 | 5 | 17,789 (0%) | 0% | 779.6 | 3,898 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 780.67 per share. | 02 Mar 2026 | 3 | 17,786 (0%) | 0% | 780.7 | 2,342 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 778.50 per share. | 02 Mar 2026 | 2 | 17,794 (0%) | 0% | 778.5 | 1,557 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 787.50 per share. | 02 Mar 2026 | 2 | 17,743 (0%) | 0% | 787.5 | 1,575 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 782.50 per share. | 02 Mar 2026 | 2 | 17,782 (0%) | 0% | 782.5 | 1,565 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 781.00 per share. | 02 Mar 2026 | 2 | 17,784 (0%) | 0% | 781 | 1,562 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 777.56 per share. | 09 Feb 2026 | 57 | 17,835 (0%) | 0% | 777.6 | 44,321 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 778.50 per share. | 09 Feb 2026 | 12 | 17,823 (0%) | 0% | 778.5 | 9,342 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 776.60 per share. | 09 Feb 2026 | 10 | 17,892 (0%) | 0% | 776.6 | 7,766 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 781.40 per share. | 09 Feb 2026 | 5 | 17,812 (0%) | 0% | 781.4 | 3,907 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 779.40 per share. | 09 Feb 2026 | 5 | 17,818 (0%) | 0% | 779.4 | 3,897 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 783.33 per share. | 09 Feb 2026 | 3 | 17,808 (0%) | 0% | 783.3 | 2,350 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 786.50 per share. | 09 Feb 2026 | 2 | 17,804 (0%) | 0% | 786.5 | 1,573 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 786.00 per share. | 09 Feb 2026 | 1 | 17,806 (0%) | 0% | 786 | 786 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 785.00 per share. | 09 Feb 2026 | 1 | 17,807 (0%) | 0% | 785 | 785 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 783.00 per share. | 09 Feb 2026 | 1 | 17,811 (0%) | 0% | 783 | 783 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 780.00 per share. | 09 Feb 2026 | 1 | 17,817 (0%) | 0% | 780 | 780 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 776.00 per share. | 09 Feb 2026 | 1 | 17,902 (0%) | 0% | 776 | 776 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 788.00 per share. | 09 Feb 2026 | 1 | 17,803 (0%) | 0% | 788 | 788 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 1,962 | 1,962 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 155 | 17,903 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,958 | 1,958 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 166 | 17,748 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1048.50 per share. | 01 Oct 2024 | 12 | 17,624 (0%) | 0% | 1048.5 | 12,582 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1047.42 per share. | 01 Oct 2024 | 12 | 17,636 (0%) | 0% | 1047.4 | 12,569 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1049.67 per share. | 01 Oct 2024 | 9 | 17,615 (0%) | 0% | 1049.7 | 9,447 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1046.56 per share. | 01 Oct 2024 | 9 | 17,648 (0%) | 0% | 1046.6 | 9,419 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1044.67 per share. | 01 Oct 2024 | 9 | 17,664 (0%) | 0% | 1044.7 | 9,402 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1051.56 per share. | 01 Oct 2024 | 9 | 17,600 (0%) | 0% | 1051.6 | 9,464 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1045.29 per share. | 01 Oct 2024 | 7 | 17,657 (0%) | 0% | 1045.3 | 7,317 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1050.67 per share. | 01 Oct 2024 | 6 | 17,609 (0%) | 0% | 1050.7 | 6,304 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1043.40 per share. | 01 Oct 2024 | 5 | 17,673 (0%) | 0% | 1043.4 | 5,217 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1052.50 per share. | 01 Oct 2024 | 4 | 17,596 (0%) | 0% | 1052.5 | 4,210 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1053.50 per share. | 01 Oct 2024 | 4 | 17,592 (0%) | 0% | 1053.5 | 4,214 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1041.33 per share. | 01 Oct 2024 | 3 | 17,679 (0%) | 0% | 1041.3 | 3,124 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1055.00 per share. | 01 Oct 2024 | 3 | 17,589 (0%) | 0% | 1055 | 3,165 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1056.67 per share. | 01 Oct 2024 | 3 | 17,586 (0%) | 0% | 1056.7 | 3,170 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1057.50 per share. | 01 Oct 2024 | 2 | 17,584 (0%) | 0% | 1057.5 | 2,115 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1059.50 per share. | 01 Oct 2024 | 2 | 17,582 (0%) | 0% | 1059.5 | 2,119 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1042.00 per share. | 01 Oct 2024 | 1 | 17,678 (0%) | 0% | 1042 | 1,042 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1172.75 per share. | 03 Sep 2024 | 16 | 17,753 (0%) | 0% | 1172.8 | 18,764 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1183.50 per share. | 03 Sep 2024 | 8 | 17,709 (0%) | 0% | 1183.5 | 9,468 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1179.62 per share. | 03 Sep 2024 | 8 | 17,717 (0%) | 0% | 1179.6 | 9,437 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1175.62 per share. | 03 Sep 2024 | 8 | 17,737 (0%) | 0% | 1175.6 | 9,405 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1174.38 per share. | 03 Sep 2024 | 8 | 17,745 (0%) | 0% | 1174.4 | 9,395 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1186.20 per share. | 03 Sep 2024 | 5 | 17,699 (0%) | 0% | 1186.2 | 5,931 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1189.20 per share. | 03 Sep 2024 | 5 | 17,687 (0%) | 0% | 1189.2 | 5,946 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1188.50 per share. | 03 Sep 2024 | 4 | 17,692 (0%) | 0% | 1188.5 | 4,754 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1185.75 per share. | 03 Sep 2024 | 4 | 17,704 (0%) | 0% | 1185.8 | 4,743 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1178.75 per share. | 03 Sep 2024 | 4 | 17,725 (0%) | 0% | 1178.8 | 4,715 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1177.75 per share. | 03 Sep 2024 | 4 | 17,729 (0%) | 0% | 1177.8 | 4,711 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1176.75 per share. | 03 Sep 2024 | 4 | 17,733 (0%) | 0% | 1176.8 | 4,707 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1170.50 per share. | 03 Sep 2024 | 4 | 17,769 (0%) | 0% | 1170.5 | 4,682 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1169.00 per share. | 03 Sep 2024 | 4 | 17,773 (0%) | 0% | 1169 | 4,676 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1166.50 per share. | 03 Sep 2024 | 4 | 17,778 (0%) | 0% | 1166.5 | 4,666 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1191.00 per share. | 03 Sep 2024 | 4 | 17,682 (0%) | 0% | 1191 | 4,764 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1188.00 per share. | 03 Sep 2024 | 3 | 17,696 (0%) | 0% | 1188 | 3,564 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1184.00 per share. | 03 Sep 2024 | 1 | 17,708 (0%) | 0% | 1184 | 1,184 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1167.00 per share. | 03 Sep 2024 | 1 | 17,777 (0%) | 0% | 1167 | 1,167 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1190.00 per share. | 03 Sep 2024 | 1 | 17,686 (0%) | 0% | 1190 | 1,190 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1091.46 per share. | 01 Aug 2024 | 13 | 17,811 (0%) | 0% | 1091.5 | 14,189 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1090.27 per share. | 01 Aug 2024 | 11 | 17,824 (0%) | 0% | 1090.3 | 11,993 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1089.57 per share. | 01 Aug 2024 | 7 | 17,835 (0%) | 0% | 1089.6 | 7,627 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1093.43 per share. | 01 Aug 2024 | 7 | 17,797 (0%) | 0% | 1093.4 | 7,654 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1092.57 per share. | 01 Aug 2024 | 7 | 17,804 (0%) | 0% | 1092.6 | 7,648 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1065.33 per share. | 01 Aug 2024 | 6 | 17,873 (0%) | 0% | 1065.3 | 6,392 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1070.50 per share. | 01 Aug 2024 | 4 | 17,863 (0%) | 0% | 1070.5 | 4,282 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1066.25 per share. | 01 Aug 2024 | 4 | 17,869 (0%) | 0% | 1066.3 | 4,265 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1088.67 per share. | 01 Aug 2024 | 3 | 17,842 (0%) | 0% | 1088.7 | 3,266 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1095.33 per share. | 01 Aug 2024 | 3 | 17,793 (0%) | 0% | 1095.3 | 3,286 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1096.33 per share. | 01 Aug 2024 | 3 | 17,790 (0%) | 0% | 1096.3 | 3,289 | Common Stock |
| Regeneron Pharma | Arthur Frederick Ryan | Director | Sale of securities on an exchange or to another person at price $ 1097.67 per share. | 01 Aug 2024 | 3 | 17,787 (0%) | 0% | 1097.7 | 3,293 | Common Stock |